MARKET

BBI

BBI

Brickell Biotech Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.000
0.000
0.00%
Opening 14:04 12/06 EST
OPEN
1.950
PREV CLOSE
2.000
HIGH
2.010
LOW
1.950
VOLUME
22.41K
TURNOVER
--
52 WEEK HIGH
9.31
52 WEEK LOW
1.800
MARKET CAP
15.62M
P/E (TTM)
-1.0955
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of BBI and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

BBI News

  • The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission
  • Benzinga.1d ago
  • The Daily Biotech Pulse: Therapix To Reverse Merge With CBD Company, Crispr Gene Editing Therapy Readout
  • Benzinga.11/19 12:56
  • Brickell Biotech reports Q3 results
  • seekingalpha.11/14 02:20
  • Brickell Biotech Q3 EPS $(1.65) Up From $(5.98) YoY, Sales $1.183M Down From $3.042M YoY
  • Benzinga.11/13 21:15

More

Industry

Biotechnology & Medical Research
+1.05%
Pharmaceuticals & Medical Research
+0.66%

Hot Stocks

Name
Price
%Change

About BBI

Brickell Biotech, Inc., formerly Vical Incorporated, is a clinical-stage pharmaceutical company that focuses on the development of therapeutics for the treatment of skin diseases. The Company’s pipeline consists of molecular entities targeting the treatment of the indications, such as hyperhidrosis, cutaneous T-cell lymphoma, allergic contact dermatitis, psoriasis and androgenic alopecia. The Company’s product candidates include BBI-3000, BBI-6000 and Sofpironium Bromide. Sofpironium Bromide is a topical soft anticholinergic for axillary hyperhidrosis. BBI-3000 is an oral rexinoid for cutaneous T-cell lymphoma. BBI-6000 is a retinoic acid-related orphan nuclear receptor gamma antagonist, which is develops for psoriasis.
More

Webull offers Brickell Biotech Inc (BBI) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.